University of Michigan Researchers Develop Highly Potent Prostate Cancer Therapy
New therapeutic molecules have demonstrated approximately 1,000 times more potency in tumor cells than standard combinations of inhibitors in preclinical prostate cancer tests, according to Bioengineer.